Literature DB >> 35474485

Impact of pectin with various esterification degrees on the profiles of gut microbiota and serum metabolites.

Quanyong Wu1, Linlin Fan1, Huizi Tan2, Yanli Zhang1, Qingying Fang1, Jingrui Yang1, Steve W Cui1,3, Shaoping Nie4.   

Abstract

Colitis is generally affected by multiple factors, including the dysbiosis of intestinal microbiota, and may affect organs outside colon through circulation. Pectin, which is an edible polysaccharide widely present in plant cell walls, has been proved in our previous study to possess preventive potentials against acute ulcerative colitis, especially when the esterification degree is less than 50%. This study aimed to clarify the underlying correlations of gut microbiome and serum metabolites with the preventive effects of pectin with different esterification degrees (H121, L13, and L102) against colitis in mice. MiSeq sequencing data showed that symbiotic bacteria especially beneficial Lactobacillus and Bifidobacterium were enriched by pectin intake. Fiber consumers such as Prevotella and Bacteroides actively responded to L13 pectin, particularly under high dosage (L13-H). In addition, the abnormal abundance of Akkermansia associated with colitis would not appear in mice who had been provided with any of the three pectins before dextran sulfate sodium (DSS) treatment. Furthermore, pre-treatment of H121 and L13 pectins could improve the serum glycerophospholipids such as phosphatidylcholine (PC) and phosphatidylethanolamine (PE). In contrast, lysophosphatidic acid (LPA) contributing to the glycerophospholipid metabolism pathway was enriched only in the L13-H group, which has been previously proved to be associated with the epithelial barrier and intestinal homeostasis. Positive relationships between the glycerophospholipids and the dominant candidates of intestinal bacteria such as Lactobacillus indicated the joint actions of intestinal microbes and serum metabolites as well as the underlying crosstalks among gut microbiome. Therefore, the results of this research suggested that the preventive effects of low-esterified pectin on DSS-induced colitis were likely to be initiated by the enrichment of probiotics in the gut and serum glycerophospholipids. KEY POINTS: • L13 pectin remarkably improved the diversity of the gut microbiome in healthy mice. • Probiotics were enriched and abnormal Akkermansia was restored by L13 and L102 pectins. • Glycerophospholipid metabolism was significantly enriched by H121 and L13 pectins.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Colitis; Correlative analysis; Esterification degrees; Gut microbiota; Pectin; Serum metabolites

Mesh:

Substances:

Year:  2022        PMID: 35474485     DOI: 10.1007/s00253-022-11926-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  25 in total

1.  The microbiome and inflammatory bowel disease.

Authors:  Kerri L Glassner; Bincy P Abraham; Eamonn M M Quigley
Journal:  J Allergy Clin Immunol       Date:  2020-01       Impact factor: 10.793

2.  Characterization of a novel extracellular α-amylase from Ruminococcus bromii ATCC 27255 with neopullulanase-like activity.

Authors:  Jong-Hyun Jung; Yu-Kyung An; Su-Yeong Son; So-Young Jeong; Dong-Ho Seo; Min-Kyu Kim; Cheon-Seok Park
Journal:  Int J Biol Macromol       Date:  2019-03-02       Impact factor: 6.953

3.  Preventive effects of pectin with various degrees of esterification on ulcerative colitis in mice.

Authors:  Linlin Fan; Sheng Zuo; Huizi Tan; Jielun Hu; Jiaobo Cheng; Quanyong Wu; Shaoping Nie
Journal:  Food Funct       Date:  2020-04-30       Impact factor: 5.396

Review 4.  Phosphatidylethanolamine Metabolism in Health and Disease.

Authors:  Elizabeth Calzada; Ouma Onguka; Steven M Claypool
Journal:  Int Rev Cell Mol Biol       Date:  2015-10-31       Impact factor: 6.813

5.  A reference map of potential determinants for the human serum metabolome.

Authors:  Noam Bar; Tal Korem; Omer Weissbrod; David Zeevi; Daphna Rothschild; Sigal Leviatan; Noa Kosower; Maya Lotan-Pompan; Adina Weinberger; Caroline I Le Roy; Cristina Menni; Alessia Visconti; Mario Falchi; Tim D Spector; Jerzy Adamski; Paul W Franks; Oluf Pedersen; Eran Segal
Journal:  Nature       Date:  2020-11-11       Impact factor: 49.962

Review 6.  Emerging treatment options for extraintestinal manifestations in IBD.

Authors:  Thomas Greuter; Florian Rieder; Torsten Kucharzik; Laurent Peyrin-Biroulet; Alain M Schoepfer; David T Rubin; Stephan R Vavricka
Journal:  Gut       Date:  2020-08-26       Impact factor: 31.793

7.  Diet rapidly and reproducibly alters the human gut microbiome.

Authors:  Lawrence A David; Corinne F Maurice; Rachel N Carmody; David B Gootenberg; Julie E Button; Benjamin E Wolfe; Alisha V Ling; A Sloan Devlin; Yug Varma; Michael A Fischbach; Sudha B Biddinger; Rachel J Dutton; Peter J Turnbaugh
Journal:  Nature       Date:  2013-12-11       Impact factor: 49.962

8.  Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation.

Authors:  M Glymenaki; A Barnes; S O'Hagan; G Warhurst; A J McBain; I D Wilson; D B Kell; K J Else; S M Cruickshank
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

9.  Gut microbiome structure and metabolic activity in inflammatory bowel disease.

Authors:  Eric A Franzosa; Alexandra Sirota-Madi; Julian Avila-Pacheco; Nadine Fornelos; Henry J Haiser; Stefan Reinker; Tommi Vatanen; A Brantley Hall; Himel Mallick; Lauren J McIver; Jenny S Sauk; Robin G Wilson; Betsy W Stevens; Justin M Scott; Kerry Pierce; Amy A Deik; Kevin Bullock; Floris Imhann; Jeffrey A Porter; Alexandra Zhernakova; Jingyuan Fu; Rinse K Weersma; Cisca Wijmenga; Clary B Clish; Hera Vlamakis; Curtis Huttenhower; Ramnik J Xavier
Journal:  Nat Microbiol       Date:  2018-12-10       Impact factor: 17.745

10.  A metabolomics pipeline for the mechanistic interrogation of the gut microbiome.

Authors:  Shuo Han; Will Van Treuren; Curt R Fischer; Bryan D Merrill; Brian C DeFelice; Juan M Sanchez; Steven K Higginbottom; Leah Guthrie; Lalla A Fall; Dylan Dodd; Michael A Fischbach; Justin L Sonnenburg
Journal:  Nature       Date:  2021-07-14       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.